EGFR and central nervous system cancer: Interestingly, the tumor suppressive role of miR-219 has been proven in glioma cells by targeting Sal-like protein (Sall4; Jiang et al., 2017) and epidermal growth factor receptor (EGFR; Rao et al., 2013).